Davis Polk lawyers discuss the Federal Trade Commission’s recently finalized rule banning non-compete covenants with employees and other workers. While it remains to be seen whether the...

We review key developments in anti-corruption and FCPA enforcement and look ahead at what to expect for the rest of the year. Topics include:Notable DOJ and SEC enforcement actions and tr...

Davis Polk hosts a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strategies...

We discuss selected key US and UK considerations for the preparation of your upcoming annual report on Form 20-F. We cover hot topics (including SEC and FCA focus areas) and recent disclo...

Please join us as we review key developments from the first half of the year and the outlook for the second half in anti-corruption and FCPA enforcement and related areas. Topics will inc...

We discuss some of this year’s key enforcement trends and policy and regulatory developments in U.S. sanctions and anti-money laundering. Topics include:Russia sanctions and other recen...

Davis Polk is pleased to announce a webinar on the new SEC-mandated NYSE and Nasdaq clawback listing standards. Join lawyers from our Executive Compensation and Capital Markets practices ...

Capital Markets partner Michael Kaplan discusses IPO considerations for ad-tech companies with Stephen Walker, CFO of Taboola. Stephen shares insights learned from Taboola’s IPO in 2021...

We invite you to view a webinar in which Davis Polk lawyers review recent FCPA and anti-corruption developments and discuss the outlook for 2023. Topics include:Policy and guidance develo...

Davis Polk recently hosted its second in its current series of webinars focused on legal considerations for life sciences and healthcare companies. In this second installment, Davis Polk ...